Phoenix Wealth Advisors reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 61.4% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,652 shares of the healthcare conglomerate’s stock after selling 2,630 shares during the quarter. Phoenix Wealth Advisors’ holdings in UnitedHealth Group were worth $836,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group during the third quarter valued at about $27,000. Global Wealth Strategies & Associates boosted its holdings in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $32,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group during the third quarter valued at approximately $37,000. Finally, Quarry LP raised its stake in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 37 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on the company. Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, TD Cowen raised their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $627.74.
Insider Transactions at UnitedHealth Group
In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.33% of the company’s stock.
UnitedHealth Group Price Performance
NYSE UNH opened at $519.08 on Thursday. The stock has a market capitalization of $477.70 billion, a price-to-earnings ratio of 33.49, a PEG ratio of 1.42 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The business’s fifty day moving average price is $545.26 and its 200-day moving average price is $564.10.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.75 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.62%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- What is a Dividend King?
- Oracle Announces Game-Changing News for the AI Industry
- What Investors Need to Know to Beat the Market
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Options Trading – Understanding Strike Price
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.